Your browser doesn't support javascript.
loading
Ophthalmic Timolol and Hospitalization for Symptomatic Bradycardia and Syncope: A Case Series.
Abbas, Syed A; Hamadani, Syeda M; Ahmad, Umair; Desai, Aditi; Kitchloo, Karishma.
Afiliação
  • Abbas SA; Internal Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, USA.
  • Hamadani SM; Internal Medicine, Fatima Memorial Hospital College of Medicine and Dentistry, Lahore, PAK.
  • Ahmad U; Internal Medicine, Fatima Memorial Hospital College of Medicine and Dentistry, Lahore, PAK.
  • Desai A; Internal Medicine, Ittefaq Trust Hospital, Lahore, PAK.
  • Kitchloo K; Internal Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, USA.
Cureus ; 12(3): e7270, 2020 Mar 14.
Article em En | MEDLINE | ID: mdl-32292680
ABSTRACT
Topical beta-blockers are commonly used for the management of primary open angle glaucoma (POAG). One of the rare but serious side effects of the topical beta-blockers is bradycardia, defined as a heart rate below 60 beats per minute. In few cases, the heart rate drops to much lower level resulting in syncope or symptomatic bradycardia. Topical beta-blockers are still widely used for POAG even though there are much better medications available. We present a series of four cases of symptomatic bradycardia resulting from the use of timolol eye drops and after discontinuation of the eye drops, heart rate improved to normal range (60-100 beats per minute).
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article